Active Pharmaceutical Ingredients
Rabeprazole DR Pellets are delayed-release multiparticulate systems designed for the oral delivery of Rabeprazole Sodium, a potent proton pump inhibitor (PPI) used in the treatment of acid-related gastrointestinal disorders such as GERD, duodenal ulcers, and Zollinger–Ellison syndrome. These enteric-coated pellets are engineered to protect the acid-labile drug from gastric degradation and ensure precise release in the intestinal environment, promoting improved absorption and therapeutic effectiveness. Utilizing advanced layering and enteric coating technologies, the pellets offer uniform size, excellent flow characteristics, and robust acid resistance.
| Component | Function |
|---|---|
| Rabeprazole Sodium | Active Pharmaceutical Ingredient (API) |
| Sugar Spheres / MCC Pellets | Core pellet material |
| Hydroxypropyl Methylcellulose (HPMC) | Rate-controlling membrane polymer |
| Methacrylic Acid Copolymers (Eudragit L100 / S100) | Enteric coating polymer |
| Polyvinyl Acetate Phthalate (PVAP) | Additional acid-resistant polymer |
| Triethyl Citrate | Plasticizer for film flexibility |
| Talc | Anti-adherent |
| Colloidal Silicon Dioxide | Glidant |
| Isopropyl Alcohol / Purified Water | Solvent system |
Salius Pharma offers Rabeprazole DR Pellets manufactured in USFDA-inspected, WHO-GMP-compliant facilities using state-of-the-art pelletization and enteric coating technologies. Our pellets provide robust acid resistance, excellent flow properties, and reliable delayed drug release tailored to diverse formulation needs. With full regulatory support, custom strength adjustments, and proven international shipping logistics, our products are ideal for seamless incorporation into finished dosage forms for both regulated and emerging markets.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Rabeprazole DR Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
Rabeprazole DR Pellets are coated with acid-resistant polymers that prevent degradation in the stomach, allowing precise release in the intestine for optimal absorption and therapeutic efficacy.
Yes. They are suitable for capsule filling, sachets, or direct tablet compression, providing manufacturers flexibility in oral formulation development.
Salius Pharma offers custom drug loads, pellet sizes, coating types, and delayed-release profiles, enabling compliance with regional regulatory requirements and formulation specifications.
All batches are GMP-manufactured, tested for content uniformity, dissolution, and stability, and shipped in export-grade packaging with complete regulatory documentation (CoA, MSDS, stability reports) to support smooth international distribution.